EULEXIN Drug Patent Profile
✉ Email this page to a colleague
When do Eulexin patents expire, and when can generic versions of Eulexin launch?
Eulexin is a drug marketed by Schering and is included in one NDA.
The generic ingredient in EULEXIN is flutamide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flutamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eulexin
A generic version of EULEXIN was approved as flutamide by WAYLIS THERAP on September 18th, 2001.
Summary for EULEXIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Clinical Trials: | 16 |
Patent Applications: | 4,988 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EULEXIN at DailyMed |
Recent Clinical Trials for EULEXIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fudan University | Phase 2 |
University of Virginia | Phase 1 |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for EULEXIN
US Patents and Regulatory Information for EULEXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | EULEXIN | flutamide | CAPSULE;ORAL | 018554-001 | Jan 27, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EULEXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | EULEXIN | flutamide | CAPSULE;ORAL | 018554-001 | Jan 27, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | EULEXIN | flutamide | CAPSULE;ORAL | 018554-001 | Jan 27, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | EULEXIN | flutamide | CAPSULE;ORAL | 018554-001 | Jan 27, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EULEXIN
See the table below for patents covering EULEXIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S61118324 | NOVEL THERAPEUTICAL COMPOSITION USING LH_RH OR AGONIST | ⤷ Try a Trial |
South Africa | 8005791 | ⤷ Try a Trial | |
Japan | H059129 | NEW THERAPEUTIC DRUG USING LH-RH OR AGONIST | ⤷ Try a Trial |
Japan | H0479325 | ⤷ Try a Trial | |
Australia | 3726985 | ⤷ Try a Trial | |
Japan | S6237018 | ⤷ Try a Trial | |
Japan | 2761988 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |